AI	Artificial intelligence.
BC	Breast cancer.
CNNs	Convolutional neural networks.
DG	DeepGrade.
DL	Deep learning.
FDA	Food and Drug Administration.
HER2	Human epidermal growth factor receptor 2.
H&E	Hematoxylin and eosin.
HR	Hormone receptor.
HRD	Homologous recombination deficiency.
IHC	Immunohistochemistry.
ML	Machine learning.
OS	Overall survival.
PD-L1	Programmed Death Ligand-1.
PHH3	Phosphorylated Histone H3.
ROI	Regions of interest.
SISH	Self-supervised image search for histology.
TILs	Tumor infiltrating lymphocytes.
TNBC	Triple-negative breast cancer.
TME	Tumor microenvironment.
WSI	Whole-slide imaging.